INDV logo

INDIVIOR PHARMACEUTICALS INC

INDVNASDAQ
🏆 #1425 by market capUS Equity
$807.16▲ $7.67 (+0.95%)
Simulated price
🔔
Track INDV
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 0.9%
7d▲ 2149.6%
14d▲ 2247.8%
30d▲ 2210.1%
ytd▲ 2149.6%
1y▲ 3247.8%
🏦Market Cap
$4.35B
Small Cap
📈Revenue Growth (YoY)
+13.6%
Healthy
📊Gross Margin
82.0%
High
💵FCF Margin
16.7%
Healthy
⚖️P/S Ratio
3.3x
Fair
Otter Score
64
Fair

Trading Snapshot

Day Range
$801.42 – $814.86
52-Week Range
$22.56 – $42.81
Volume
$2.74B
Avg Volume
$1.84B
Shares Outstanding
121.0M
Next Earnings
Nov 7, 2026

Fundamentals Snapshot

Annual Revenue
$1.24B
Last Q Revenue
$343M
P/E Ratio
12.3
P/S Ratio
3.3x
EPS (TTM)
$2.78
Dividend Yield
—
Dilution (1yr)
−2.4%

Why Investors Own INDV

  • ✓High-growth profile — revenue up +19.8% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 51% gross margin and 11% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

INDV logo

INDIVIOR PHARMACEUTICALS INC

INDV
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1.2B▲ +4.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
80.1%▼ −0.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$265M▲ +728.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$94M▼ −1980.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
125.0M▼ −2.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$156M▼ −$100M YoY
StockOtter · stockotter.space

About INDIVIOR PHARMACEUTICALS INC

Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
64/100

Analyst Price Target

ⓘ
Average Target
$1,010.43
▲ +25.2% Upside
High Target$1,206.54
Low Target$900.15
Based on 32 analysts

Latest News & Updates

🚀
Bloomberg·2h ago

INDIVIOR PHARMACEUTICALS INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
CNBC·5h ago

Analysts lift INDV price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Reuters·1d ago

INDIVIOR PHARMACEUTICALS INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.